ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2933

HLA-DR3 Restricted T Cell Response to Smd and Ro60 Reveals Multiple Cross-Reactive Intra- and Inter-Molecular T Cell Epitopes: Unique Antigenic Structures of Lupus-Related Auto-Antigens and the Basis for B Cell Epitope Spreading

Zhenhuan Zhao1, Jiling Ren1, Chao Dai2, Carol Kannapell1, Qian Wang3, Felicia Gaskin4 and Shu Man Fu5, 1Medicine/CIIR/Rheumatology, University of Virginia, Charlottesville, VA, 2Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, VA, 3University of Virginia, Charlottesville, VA, 4Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, 5Department of Medicine, University of Virginia, Charlottesville, VA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: auto-immunity and autoantigens, B cells, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Complex auto-Abs targeting nuclear proteins is a hallmark of systemic lupus erythematosus (SLE). It is documented that this complexity is the result of “B cell epitope spreading” with unique patterns. The generation of SLE-related auto-Abs is T cell dependent and preferentially restricted to HLA-DR3 (DR3) and DR2. The current hypotheses for the generation of these auto-Abs such as the “B cell epitope mimicry hypothesis” and the “particle hypothesis” in that a limited auto-reactive T cell population is able to provide T cell help to B cells of multiple specificities, are inadequate to account for the above-stated observations. The results of our analysis of DR3 restricted T cell response to SmD and Ro60 provides an alternative to the current paradigms.

Methods: T-T hybridomas were generated by fusing lymph node cells from DR3+AE0 mice immunized with SmD in IFA with BW5147TCR-/-. IL-2 in the supernatants of T-T hybridomas stimulated by SmD with syngeneic splenic cells as APC was determined by ELISA. SmD T cell epitope regions were determined with 15mers overlapping by 3 amino acids covering the span of SmD with the established T-T hybridomas. The core epitopes were determined by alanine substitutions. TCR utilized by T-T hybridomas were sequenced. For response to SmD peptides and its mimics DR3+AE0 mice were immunized with 100µg peptide in CFA on day 1 and 50 µg of the immunogen in IFA on days 14 and 28. Sera were collected at 42, 56, 70, 90 and 120 days and assayed for Abs to SLE-related auto-Ags.

Results: Multiple T-T hybridomas reactive to SmD were generated by 7 fusions. Many hybridomas were found to be reactive with more than one T cell epitope within SmD. Some of them reacted with SmB and the A protein (ARNP) of the snRNA particle. The core epitopes of 7 SmD peptides were ascertained by alanine substitution and they have no sequence homology. Several of 15mers of these core epitopes induced B cell epitope spreading to SmB, ARNP and certain proteins in the Ro60/La system. Some bacterial peptides induced B cell epitope spreading in a manner similar to that of the SmD peptide. Interestingly, cross reactive B cell epitopes were demonstrated among the SmD peptide and its bacterial mimics. Similar findings were obtained regarding the T cell responses to Ro60 and its 15mers.

Conclusion: The results showed that SLE-related auto-Ags have multiple cross-reactive intramolecular T cell epitopes. This is a feature shared by other auto-Ags such as GAD65 in type 1 DM and myelin basic protein in EAE, a model for multiple sclerosis. Although not the subject of this abstract, there are cross-reactive inter and intra molecular B cell epitopes among the SLE-related Ags. These structural features are likely the reasons why they are the targeted in autoimmunity. The presence of multiple cross reactive intermolecular T cell epitopes provides the basis for DR3 restricted B cell epitope spreading in SLE. The cross-reactivities at both T and B cell levels of the bacterial molecular mimics and their auto-epitopes provide a scenario for the presence of SLE-related auto-Abs in normal DR3 individuals.


Disclosure: Z. Zhao, None; J. Ren, None; C. Dai, None; C. Kannapell, None; Q. Wang, None; F. Gaskin, None; S. M. Fu, None.

To cite this abstract in AMA style:

Zhao Z, Ren J, Dai C, Kannapell C, Wang Q, Gaskin F, Fu SM. HLA-DR3 Restricted T Cell Response to Smd and Ro60 Reveals Multiple Cross-Reactive Intra- and Inter-Molecular T Cell Epitopes: Unique Antigenic Structures of Lupus-Related Auto-Antigens and the Basis for B Cell Epitope Spreading [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/hla-dr3-restricted-t-cell-response-to-smd-and-ro60-reveals-multiple-cross-reactive-intra-and-inter-molecular-t-cell-epitopes-unique-antigenic-structures-of-lupus-related-auto-antigens-and-the-basis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-dr3-restricted-t-cell-response-to-smd-and-ro60-reveals-multiple-cross-reactive-intra-and-inter-molecular-t-cell-epitopes-unique-antigenic-structures-of-lupus-related-auto-antigens-and-the-basis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology